Report Detail
Global Sunitinib Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024
- RnM3748145 |
- 14 September, 2019 |
- Global |
- 108 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.
Scope of the Report:
The global Sunitinib Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sunitinib Drug.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Sunitinib Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Sunitinib Drug market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
12.5 mg Capsules
25 mg Capsules
37.5 mg Capsules
50 mg Capsules
Market Segment by Applications, can be divided into
Kidney cancer
GIST
pNET
Table of Contents
1 Sunitinib Drug Market Overview
- 1.1 Product Overview and Scope of Sunitinib Drug
- 1.2 Classification of Sunitinib Drug by Types
- 1.2.1 Global Sunitinib Drug Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Sunitinib Drug Revenue Market Share by Types in 2018
- 1.2.3 12.5 mg Capsules
- 1.2.4 25 mg Capsules
- 1.2.5 37.5 mg Capsules
- 1.2.6 50 mg Capsules
- 1.3 Global Sunitinib Drug Market by Application
- 1.3.1 Global Sunitinib Drug Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 Kidney cancer
- 1.3.3 GIST
- 1.3.4 pNET
- 1.4 Global Sunitinib Drug Market by Regions
- 1.4.1 Global Sunitinib Drug Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Sunitinib Drug Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Sunitinib Drug Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sunitinib Drug Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Sunitinib Drug Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sunitinib Drug Status and Prospect (2014-2024)
- 1.5 Global Market Size of Sunitinib Drug (2014-2024)
2 Manufacturers Profiles
- 2.1 Pfizer
- 2.1.1 Business Overview
- 2.1.2 Sunitinib Drug Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Pfizer Sunitinib Drug Revenue, Gross Margin and Market Share (2017-2018)
3 Global Sunitinib Drug Market Competition, by Players
- 3.1 Global Sunitinib Drug Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Sunitinib Drug Players Market Share
- 3.2.2 Top 10 Sunitinib Drug Players Market Share
- 3.3 Market Competition Trend
4 Global Sunitinib Drug Market Size by Regions
- 4.1 Global Sunitinib Drug Revenue and Market Share by Regions
- 4.2 North America Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 4.3 Europe Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 4.5 South America Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Sunitinib Drug Revenue and Growth Rate (2014-2019)
5 North America Sunitinib Drug Revenue by Countries
- 5.1 North America Sunitinib Drug Revenue by Countries (2014-2019)
- 5.2 USA Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 5.3 Canada Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Sunitinib Drug Revenue and Growth Rate (2014-2019)
6 Europe Sunitinib Drug Revenue by Countries
- 6.1 Europe Sunitinib Drug Revenue by Countries (2014-2019)
- 6.2 Germany Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 6.3 UK Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 6.4 France Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 6.5 Russia Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 6.6 Italy Sunitinib Drug Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Sunitinib Drug Revenue by Countries
- 7.1 Asia-Pacific Sunitinib Drug Revenue by Countries (2014-2019)
- 7.2 China Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 7.3 Japan Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 7.4 Korea Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 7.5 India Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Sunitinib Drug Revenue and Growth Rate (2014-2019)
8 South America Sunitinib Drug Revenue by Countries
- 8.1 South America Sunitinib Drug Revenue by Countries (2014-2019)
- 8.2 Brazil Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Sunitinib Drug Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Sunitinib Drug by Countries
- 9.1 Middle East and Africa Sunitinib Drug Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 9.3 UAE Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Sunitinib Drug Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Sunitinib Drug Revenue and Growth Rate (2014-2019)
10 Global Sunitinib Drug Market Segment by Type
- 10.1 Global Sunitinib Drug Revenue and Market Share by Type (2014-2019)
- 10.2 Global Sunitinib Drug Market Forecast by Type (2019-2024)
- 10.3 12.5 mg Capsules Revenue Growth Rate (2014-2024)
- 10.4 25 mg Capsules Revenue Growth Rate (2014-2024)
- 10.5 37.5 mg Capsules Revenue Growth Rate (2014-2024)
- 10.6 50 mg Capsules Revenue Growth Rate (2014-2024)
11 Global Sunitinib Drug Market Segment by Application
- 11.1 Global Sunitinib Drug Revenue Market Share by Application (2014-2019)
- 11.2 Sunitinib Drug Market Forecast by Application (2019-2024)
- 11.3 Kidney cancer Revenue Growth (2014-2019)
- 11.4 GIST Revenue Growth (2014-2019)
- 11.5 pNET Revenue Growth (2014-2019)
12 Global Sunitinib Drug Market Size Forecast (2019-2024)
- 12.1 Global Sunitinib Drug Market Size Forecast (2019-2024)
- 12.2 Global Sunitinib Drug Market Forecast by Regions (2019-2024)
- 12.3 North America Sunitinib Drug Revenue Market Forecast (2019-2024)
- 12.4 Europe Sunitinib Drug Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Sunitinib Drug Revenue Market Forecast (2019-2024)
- 12.6 South America Sunitinib Drug Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Sunitinib Drug Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Summary:
Get latest Market Research Reports on Sunitinib Drug. Industry analysis & Market Report on Sunitinib Drug is a syndicated market report, published as Global Sunitinib Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Sunitinib Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
